Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial - Quiz - MDSpire

Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial

  • By

  • Xinying Shi

  • Anran Zhao

  • Yi Ding

  • Lingfeng Gu

  • Tongtong Yang

  • Hao Wang

  • Qiming Wang

  • Sibo Wang

  • Liansheng Wang

  • February 21, 2026

  • 0 min

Share

Original Source(s)

Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial

  • by Xinying Shi, Anran Zhao, Yi Ding, Lingfeng Gu, Tongtong Yang, Hao Wang, Qiming Wang, Sibo Wang, Liansheng Wang

  • February 21, 2026

Related Content

Transcriptomic signatures and immune microenvironment of acute rejection after heart transplantation: an integrated bioinformatics analysis

Heart failure risk prediction based on machine learning and interpretability analysis

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study